COPYRIGHT© 2018 吉林紫鑫药业股份有限公司
Science and technology help Jilin ginseng industry innovation
The machine roared, the tower crane hoisted, and the transport vehicles shuttled. On June 2nd, in the Jilin Ginseng Life Science and Technology Industrial Park in the foothills of Changbai Mountain, hundreds of workers were busy and busy, and they had a hot construction scene.
When it comes to ginseng, people naturally think of Jilin. Not only because of the large production of local ginseng, but also because of its authenticity. Since the implementation of the ginseng revitalization project in Jilin Province in 2010, the total output value of the participating industry has increased from 22 billion yuan in 2010 to 55 billion yuan in 2016. It is estimated that 100 billion yuan will be realized by 2020.
To the ginseng industry cluster development
Jilin Ginseng Life Science and Technology Industrial Park is one of the projects for the development of ginseng industry in Jilin Province. It is a high-tech industrial park with the theme of ginseng and life. The park is built on the basis of the excellent ecological environment of the Changbai Mountain area, abundant supply of ginseng raw materials and convenient location conditions, and is included in the key projects implemented in the “13th Five-Year Plan” of Jilin Province and Baishan City.
The park is centered around the “ginseng”, “health” and “technology” ginseng life and health industry chain, focusing on the introduction of major projects with good development prospects and cutting-edge technology, which will drive the development of the park industry. At present, several core projects introduced in the park include the ginsenoside Rg3 series of pharmaceutical products, and the ginsenoside Rg3 series of pharmaceuticals is the only antiviral ginseng drug found in the world.
According to the person in charge of the project, since the start of last year, the total number of enterprises entering the park has reached 12, and 19 contracted and invested projects have been signed, with a total contracted capital of 4.5 billion yuan. Among them, the total investment of ginsenoside Rg3 series pharmaceutical project reached 780 million yuan. It is planned to complete the civil engineering of ginsenoside Rg3 eye ointment project in July, and install and debug equipment before December and strive to obtain new drug certificate. The Changbai Mountain Black Participation and R&D project with a total investment of 1.2 billion yuan has been signed nearly 500 million yuan in the absence of completion.
Jilin Ginseng Life Science and Technology Industrial Park is only a microcosm of the revitalization and development of ginseng industry in Jilin Province. At present, the ginseng industry has shown a trend of cluster development.
Transfer to emerging industries
Jilin Province Ginseng Research Institute undertakes the promotion of ginseng production technology, experimental demonstration and vocational skills training of ginseng planting in the province, carries out product quality testing of ginseng and other soil quality monitoring, and participates in the formulation and promotion of national standards.
According to Chen Changbao, the president of the hospital, at present, the quality of the red ginseng, raw sun ginseng, fresh garden ginseng, vigorous ginseng, ginseng, fresh ginseng, honey ginseng, etc., and “American ginseng” The analysis and testing of the national standard of ginseng series has been completed, which will provide strong technical support for ginseng to enter product conversion.
The ginseng genome map developed by the Tonghua Municipal Government of the province, the Beijing Genomics Institute of the Chinese Academy of Sciences, and the Jilin Zixin Pharmaceutical Co., Ltd. provides a powerful technology for the cultivation, disease prevention, development of ginseng and the development of ginseng industry. support. At the same time, the sequencing of ginseng genome map is a forward-looking and strategic basic work to break the bottleneck of ginseng industry's refined and scientific development.
Jilin Province has gradually strengthened the innovation of ginseng products, integrated domestic scientific and technological resources, established a high-level research and development platform and a transformation system for results, provided ginseng product technology for provincial and internal enterprises, and built a pillar of the emerging medical health industry.
Stepping towards ginseng planting optimization project
During the “Thirteenth Five-Year Plan” period, in order to cultivate the ginseng industry into a pillar industry with a total output value of over 100 billion yuan, Jilin Province has formulated “six major projects”, including the ginseng planting optimization project.
The project includes scientifically regulating the planting scale, optimizing the planting structure, and building a standardized production base. The seedling retention area of the harvesting base is stable within 50 million square meters, the planting area of the forest is less than 800 square kilometers, and the non-forest land species size exceeds 1400. 10,000 square meters and other content.
Taking Baishan City as an example, in 2015, the city has implemented 28 high-quality safe cultivation techniques for ginseng, and the GAP production area has reached 90%. 80% of the city's ginseng production is filed. The city's ginseng (American ginseng) has a retention area of 24.5 million square meters. 47 products from 10 enterprises in the city joined the “Changbai Mountain Ginseng” brand. Jingyu County Linxiashen and American Ginseng were listed as the only two geographical indications of the Ministry of Agriculture. The provincial Changbai Mountain Ginseng brand raw material base reached 15 Linxia has developed to 340 square kilometers.